Abstract: Provided herein are systems and methods for quantitating the HLA diversity in a solid tissue or circulating tumor DNA sample that is predictive of a patient's responsiveness to immune checkpoint inhibitory therapies.
Abstract: This application relates to methods of denaturing double-stranded DNA (dsDNA). In some examples, the methods utilize dried sodium hydroxide. In some examples, the method includes loading dsDNA into a first portion of a cartridge, wherein the second portion of the cartridge contains sodium hydroxide in a dry form; and mixing the dsDNA with the sodium hydroxide, thereby denaturing the dsDNA.
Type:
Application
Filed:
December 20, 2023
Publication date:
July 4, 2024
Applicant:
Illumina, Inc.
Inventors:
Eli Carrami, Oliver Miller, Sebastien Ricoult, Eilidh Rivers, Dale Weekes
Abstract: Methods for on-flow cell selective capture and enrichment of clustered beads, general capture strategies on bead mobility on flow cell surfaces, sorting clustered and unclustered beads, and flow cell reusability for bead immobilization onto flow cells.
Abstract: A method for modifying an interstitial surface separating recesses from one another can include flowing a first fluid over the interstitial surface and into the recesses, such that the interstitial surface is substantially coated with the first fluid and the recesses are substantially filled with the first fluid; and while the first fluid remains within the recesses, replacing the first fluid coating the interstitial surface with a second fluid comprising a reagent.
Type:
Application
Filed:
December 18, 2023
Publication date:
June 27, 2024
Applicant:
Illumina, Inc.
Inventors:
Yannan Zhao, Florika Macazo, Rachel Goodridge, Emily Welch, Hassan Bohra, Sang Park, Lisa Savagian, Borhan Chueh, Thomas Brubaker, Shreshtha Mishra
Abstract: An example of a flow cell includes a substrate and a pattern of two different silanes on at least a portion of a surface of the substrate. A first polymer is attached to a first of the two different silanes and a second polymer is attached to a second of the two different silanes. The first and second polymers respectively include a first functional group and a second functional group of a functional group pair, the functional group pair being selected from the group consisting of an activated ester functional group and an azide functional group, a tetrazine functional group and an activated ester functional group, and a tetrazine functional group and an azide functional group. A first primer set is grafted to the first polymer and a second primer set is grafted to the second polymer. The first and second primer sets are different.
Abstract: In an example of a method of making a flowcell, an organic solid support including sidewalls and a top is provided. A bottom surface of the organic solid support adjacent to the sidewalls provides a laser bonding foot. In the method, the laser bonding foot is bonded to an inorganic solid support to form a channel having sidewalls and a top defined by the organic solid support.
Type:
Grant
Filed:
August 24, 2021
Date of Patent:
June 25, 2024
Assignee:
Illumina, Inc.
Inventors:
Jeffrey S. Fisher, John A. Moon, Bala Murali Venkatesan
Abstract: Reusable flow cells for sequencing which exhibit signal intensity retention over numerous use cycles, the active surface of which contains reactive sulfur moieties for reversible primer binding, methods of using such flow cells, reagents therefor, and kits containing the same.
Type:
Application
Filed:
December 13, 2023
Publication date:
June 20, 2024
Applicant:
Illumina, Inc.
Inventors:
Weixian Xi, Brian Mather, Claudia Battistella
Abstract: Systems, methods, and apparatus are described herein for aggregating genome data into bins with summary data at various levels. As described herein, a computing device may be configured to receive genome data associated with a genome. The computing device may be configured to generate an aggregate file using the received genome data. The aggregate file may include a plurality of bins at a plurality of depths. The computing device may be configured to determine summary data for respective reads associated with one or more respective portions of the genome covered by respective bins of the plurality of bins. The computing device may be configured to store the summary data for the respective reads in respective bins of the plurality of bins. The computing device may be configured to display a portion of the summary data in response to a selection of a genomic region by a user.
Type:
Application
Filed:
December 20, 2023
Publication date:
June 20, 2024
Applicant:
Illumina, Inc.
Inventors:
Andrew Warren, Benjamin Rinvelt, Max Arseneault
Abstract: An example of a resin composition includes an epoxy resin matrix, a free radical photoinitiator selected from the group consisting of 2-ethyl-9,10-dimethoxyanthracene, 2,2-dimethoxy-2-phenylacetophenone, 2-ethoxy-2-phenylacetophenone, and a phosphine oxide, and a photoacid generator. When cured, the resin composition has low or no autofluorescence when exposed to blue excitation wavelengths ranging from about 380 nm to about 480 nm or green excitation wavelengths ranging from about 510 nm to about 560 nm.
Inventors:
Timothy J. Merkel, Wayne N. George, Andrew A. Brown, Audrey Zak, Gianluca Andrea Artioli, Julia Morrison, Nikolai Romanov, Lorenzo Berti, Graham Boud
Abstract: A system includes a fluidic device, a flow control valve, a first reagent fluid reservoir fluidly connectable to the fluidic device by the flow control valve, a first fluid buffer reservoir fluidly connectable to the fluidic device by the flow control valve, and a common fluid buffer source fluidly connectable to the fluidic device by the flow control valve. The flow control valve permits flow comprising: (i) flow from the first reagent fluid reservoir to the fluidic device, (ii) flow from the common fluid buffer source to the fluidic device, (iii) flow from the fluidic device to the first fluid buffer reservoir, (iv) flow from the first reagent fluid reservoir to the fluidic device, and (v) flow from the first fluid buffer reservoir to the fluidic device.
Type:
Grant
Filed:
August 3, 2022
Date of Patent:
June 18, 2024
Assignee:
ILLUMINA, INC.
Inventors:
Wesley A. Cox-Muranami, Kay Klausing, Bradley Kent Drews, Nicholas Watson, Jennifer Olivia Foley, Murphy Hitchcock, Paul Sangiorgio, Sz-Chin Steven Lin
Abstract: A method for measuring thermal resistance between a thermal component of an instrument and a consumable includes contacting a known consumable with a thermal component to be tested; driving the thermal component using a periodic sine wave input based on a predetermined interrogation frequency; measuring temperature outputs from a thermal sensor responsive to the periodic sine wave input; multiplying the temperature outputs by a reference signal in phase with the periodic sine wave input and calculating the resultant DC signal component to determine an in-phase component X; multiplying the plurality of temperature outputs by a 90° phase-shifted reference signal and calculating the resultant DC signal component to determine a quadrature, out-of-phase component Y; calculating a phase offset responsive to the periodic sine wave input based on tan?1 (Y/X) or atan2(X,Y); and determining a resistance value for the thermal interface using a calibrated resistance-phase offset equation and the calculated phase offset.
Abstract: In accordance with embodiments herein a method for capturing cells of interest in a digital microfluidic system is provided, comprising utilizing a droplet actuator to transport a sample droplet to a microwell device. The microwell device includes a substrate having a plurality of microwells that open onto a droplet operations surface of the microwell device. The sample droplet includes cells of interest that enter the microwells. The method introduces capture beads to the microwells, and the capture elements are immobilized on the capture beads. The method utilizes the droplet actuator to transport a cell lysis reagent droplet to the microwell device. Portions of the cell lysis reagent droplet enter the microwells and, during an incubation period, cause the cells of interest to release analyte that is captured by the capture elements on the capture beads.
Type:
Grant
Filed:
December 17, 2021
Date of Patent:
June 18, 2024
Assignee:
Illumina, Inc.
Inventors:
Arash Jamshidi, Yan-you Lin, Farnaz Absalan, Sarah Stuart, Gordon Cann, Yir-Shyuan Wu, Tarun Khurana, Jeffrey S Fisher
Abstract: Provided herein include various examples of a method for manufacturing aspects of an apparatus, a sensor system. The method may include obtaining a first carrier bonded to an upper surface of the silicon wafer. This wafer includes through silicon vias (TSVs) extended through openings in a passivation stack, with electrical contacts coupled to portions of the TSVs exposed through these openings. The method may include de-bonding the first carrier from the upper surface of the silicon wafer. The method may include dicing the silicon wafer into subsections comprising dies.
Type:
Grant
Filed:
September 16, 2020
Date of Patent:
June 11, 2024
Assignee:
Illumina, Inc.
Inventors:
Arvin Emadi, Jon Aday, Ali Agah, Arnaud Rival
Abstract: Two-phase flushing systems and methods. An example method includes moving a valve to a first position to fluidly connect a first reagent reservoir containing a first reagent to a flow cell and flowing the first reagent from the first reagent reservoir to the flow cell to perform a biochemical reaction. The method includes moving the valve to a second position to fluidly connect a gas to the flow cell and flowing gas into the flow cell to expel at least a portion of the first reagent from the biochemical reaction from the flow cell. The method includes moving the valve to a third position to fluidly connect a buffer reagent reservoir containing a buffer reagent to the flow cell and flowing the buffer reagent into the flow cell.
Type:
Grant
Filed:
May 27, 2020
Date of Patent:
June 11, 2024
Assignee:
ILLUMINA, INC.
Inventors:
Nicholas Watson, Wesley A. Cox-Muranami, Cyril Delattre, Minsoung Rhee
Abstract: The present disclosure is concerned with proteins, methods, compositions, and kits for mapping of methylation status of nucleic acids, including 5-methylcytosine and 5-hydroxymethyl cytosine (5 hmC). In one embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to thymidine or modified thymidine analogues. In another embodiment, proteins are provided that selectively act on certain modified cytosines of target nucleic acids and converts them to uracil or thymidine and selectively do not act on other certain modified cytosines of target nucleic acids. Also provided are compositions and kits that include one or more of the proteins and methods for using one or more of the proteins.
Type:
Application
Filed:
December 13, 2023
Publication date:
June 6, 2024
Applicant:
ILLUMINA, INC.
Inventors:
Dewei Joel Toh, Leslie Yee Ming Beh, Shu Ting Tan, Anna Traczyk, Saurabh Nirantar, Eric Brustad, Hamed Tabatabaei Ghomi, Zahra Fahmi, Lekha Ravichandraprabhu, Colin Brown, Kayla Busby, Stephen Gross, Rebekah Karadeema, Huy Lam, Pascale Mathonet, Sarah E. Shultzaberger, Kathleen Tzeng, Allison Kathleen Yunghans
Abstract: Some examples herein provide a hydrogel on a substrate. The hydrogel includes a three-dimensional network of polymer chains; first functional groups coupled to the polymer chains; amplification primers coupled to the polymer chains via the first functional groups; and second functional groups coupled to the polymer chains and reversibly cross-linking the polymer chains to one another. Some examples herein provide a method of using a hydrogel. The method includes hybridizing a target polynucleotide to an amplification primer coupled to a hydrogel; cleaving cross-linkages within the hydrogel within which the target polynucleotide is hybridized to the amplification primer; and amplifying the target polynucleotide using additional amplification primers within the hydrogel within which the cross-linkages have been cleaved.
Type:
Application
Filed:
November 20, 2023
Publication date:
June 6, 2024
Applicant:
Illumina, Inc.
Inventors:
Hassan Bohra, Johan Basuki, Wei Wei, Brian Mather
Abstract: Systems, methods, and compositions provided herein relate to preparation of beads encapsulating biomolecules for performing sequential reactions on the biomolecules. Some embodiments include preparation of nucleic acid reactions within the bead, wherein the bead includes pores that allow diffusion of molecules into or out of the beads while retaining other molecules of interest.
Type:
Grant
Filed:
July 1, 2021
Date of Patent:
June 4, 2024
Assignee:
Illumina, Inc.
Inventors:
Steven Norberg, Dmitry K. Pokholok, Ramesh Ramji, Frank J. Steemers, Fan Zhang
Abstract: An apparatus includes a fluidic circuit, a bypass fluidic circuit, a first set of fluid wells, a second set of fluid wells, a first valve, and a second valve. The first valve operatively associated with the first set of fluid wells such that the first selectively fluidly connects any one of the first set of fluid wells to a first valve outlet. The second valve operatively associated with the fluidic circuit, the bypass fluidic circuit, the first valve outlet, and the second set of fluid wells such that the second valve selectively fluidly connects any one of the second set of fluid wells and the first valve outlet to the fluidic circuit or the first valve outlet to the bypass fluidic circuit.
Type:
Grant
Filed:
June 2, 2022
Date of Patent:
June 4, 2024
Assignee:
ILLUMINA, INC.
Inventors:
Wesley A. Cox-Muranami, James Osmus, Paul Crivelli, Bradley Kent Drews
Abstract: Described herein are heterocyclic azide-containing monomer units, copolymers comprising such heterocyclic azide-containing monomer units, substrate-bound copolymers, and oligonucleotide-bound copolymers, methods for making such copolymers and reacting them with a substrate and/or oligonucleotide, and methods of using such copolymers for immobilization of oligonucleotides to a substrate, for example for use in DNA sequencing or other diagnostic applications.
Type:
Grant
Filed:
December 9, 2019
Date of Patent:
June 4, 2024
Assignee:
Illumina Cambridge Limited
Inventors:
Wayne N. George, Xiaolin Wu, Andrew A. Brown, Donald Wellings